Bank of New York Mellon Corp - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$5,342,000
+105.5%
304,203
+13.6%
0.00%0.0%
Q2 2021$2,599,000
+1783.3%
267,902
+2347.5%
0.00%
Q4 2015$138,000
-2.1%
10,946
+1.3%
0.00%
Q3 2015$141,00010,8030.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders